Cabot Corporation

NYSE:CBT Rapport sur les actions

Capitalisation boursière : US$4.5b

Cabot Résultats passés

Passé contrôle des critères 2/6

Cabot a connu une croissance annuelle moyenne de ses bénéfices de 25.8%, tandis que le secteur Chemicals a vu ses bénéfices augmenter de en baisse à 4% par an. Les revenus ont augmenté de en hausse à un taux moyen de 1.6% par an. Le rendement des capitaux propres de Cabot est 19.4% et ses marges nettes sont de 7.9%.

Informations clés

25.81%

Taux de croissance des bénéfices

26.74%

Taux de croissance du BPA

Chemicals Croissance de l'industrie12.93%
Taux de croissance des recettes1.65%
Rendement des fonds propres19.38%
Marge nette7.86%
Dernière mise à jour des bénéfices31 Mar 2026

Mises à jour récentes des performances passées

Recent updates

Seeking Alpha Mar 26

Cabot: Competitive Pressures Due To High Tire Imports Continuing To Weigh

Summary Cabot Corporation continues to face sustained volume pressure in both Reinforcement Materials and Performance Chemicals, with management candid about ongoing macro headwinds. Despite Battery Materials revenue strength, EBIT in CBT's largest segment dropped by $28 million, and cost-cutting plus reduced capex signal a defensive near-term posture. Earnings are expected to fall by approximately 14% in fiscal 2026, with further downside risk due to recent downward EPS revisions and capacity rationalization plans. Technical analysis suggests the stock is consolidating at best, with broken support levels and weakening momentum likely leading to further downside; we maintain a bearish stance. Read the full article on Seeking Alpha
Article d’analyse Nov 03

Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...
Article d’analyse Sep 11

Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch

With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...
Article d’analyse Jul 20

Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?

Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...
Article d’analyse Jun 23

Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Article d’analyse Apr 25

These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Article d’analyse Apr 10

Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price

Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...
Article d’analyse Mar 12

A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price

Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...
Seeking Alpha Feb 13

Cabot Corporation: Reinforcing Positive Shareholder Value

Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking Alpha
Seeking Alpha Jan 30

Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)

Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking Alpha
Article d’analyse Jan 29

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...
Article d’analyse Jan 15

Is Cabot (NYSE:CBT) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Article d’analyse Jan 02

Returns On Capital Are A Standout For Cabot (NYSE:CBT)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Article d’analyse Dec 06

Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...
Seeking Alpha Nov 14

Cabot: Less Than 5% Annualized Upside

Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking Alpha
Article d’analyse Oct 31

Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Article d’analyse Oct 19

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...
Article d’analyse Oct 07

Improved Earnings Required Before Cabot Corporation (NYSE:CBT) Shares Find Their Feet

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...
Article d’analyse Sep 25

Cabot (NYSE:CBT) Is Achieving High Returns On Its Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
Article d’analyse Aug 19

Calculating The Intrinsic Value Of Cabot Corporation (NYSE:CBT)

Key Insights The projected fair value for Cabot is US$96.50 based on 2 Stage Free Cash Flow to Equity With US$99.26...
Seeking Alpha Jul 31

Cabot Corporation: Now A 'Hold' (Rating Downgrade)

Summary Cabot Corporation has seen significant positive performance, up over 44% inclusive of dividends since January 19, 2023. The company has outperformed with good overall investment performance, showing resilience towards macro challenges. Despite recent growth, Cabot is now considered a "Hold" due to valuation concerns and moderate upside potential. Read the full article on Seeking Alpha
Article d’analyse Jul 18

Cabot (NYSE:CBT) Will Pay A Dividend Of $0.43

Cabot Corporation's ( NYSE:CBT ) investors are due to receive a payment of $0.43 per share on 13th of September. Based...
Article d’analyse Jun 23

Cabot (NYSE:CBT) Looks To Prolong Its Impressive Returns

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Article d’analyse Jun 09

Why Cabot Corporation (NYSE:CBT) Could Be Worth Watching

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw a double-digit share price...
Article d’analyse May 24

Cabot's (NYSE:CBT) Dividend Will Be Increased To $0.43

The board of Cabot Corporation ( NYSE:CBT ) has announced that it will be paying its dividend of $0.43 on the 14th of...
Seeking Alpha May 16

Cabot: Reinforcement Materials Strength To Continue To Drive Earnings Forward

Summary Cabot Corporation's stock has returned approximately 38% since our 'Buy' recommendation in January. The company's Q2 earnings report showed impressive growth in both Performance Chemicals and the Reinforcement Materials business in particular. Cabot's cash flow is driving its financials, allowing for increased dividends and stock buybacks, and its forward-looking fundamentals remain bullish. Read the full article on Seeking Alpha
Article d’analyse May 13

Cabot's (NYSE:CBT) Shareholders May Want To Dig Deeper Than Statutory Profit

The market for Cabot Corporation's ( NYSE:CBT ) stock was strong after it released a healthy earnings report last week...
Article d’analyse May 10

Cabot's (NYSE:CBT) Upcoming Dividend Will Be Larger Than Last Year's

Cabot Corporation's ( NYSE:CBT ) dividend will be increasing from last year's payment of the same period to $0.43 on...
Article d’analyse May 07

Here's Why Cabot (NYSE:CBT) Has Caught The Eye Of Investors

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Ventilation des recettes et des dépenses

Comment Cabot gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

NYSE:CBT Recettes, dépenses et bénéfices (USD Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
31 Mar 263,57528126256
31 Dec 253,60730626056
30 Sep 253,71332625857
30 Jun 253,81541826360
31 Mar 253,90842626961
31 Dec 243,99141728062
30 Sep 243,99437428163
30 Jun 243,95847028060
31 Mar 243,91044326959
31 Dec 233,92443326059
30 Sep 233,93143725357
30 Jun 234,07830024257
31 Mar 234,25931523758
31 Dec 224,31834824655
30 Sep 224,32120625555
30 Jun 224,11314229056
31 Mar 223,88113030656
31 Dec 213,6319829755
30 Sep 213,40924729356
30 Jun 213,164-5431557
31 Mar 212,765-14429654
31 Dec 202,633-21929257
30 Sep 202,614-23829557
30 Jun 202,7826524654
31 Mar 203,10910326157
31 Dec 193,24312726858
30 Sep 193,33715527060
30 Jun 193,36021728165
31 Mar 193,36927328266
31 Dec 183,3437729567
30 Sep 183,242-11429566
30 Jun 183,115-13628264
31 Mar 182,966-17727961
31 Dec 172,8266926359
30 Sep 172,71724625857
30 Jun 172,61322527053
31 Mar 172,52923426951
31 Dec 162,41920926449
30 Sep 162,41114526648
30 Jun 162,46313625149
31 Mar 162,536-36625652
31 Dec 152,662-38826354
30 Sep 152,871-33627158
30 Jun 153,111-34828158

Des revenus de qualité: CBT a des bénéfices de haute qualité.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de CBT sont inférieures à celles de l'année dernière CBT. (7.9%) sont inférieures à celles de l'année dernière (10.9%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: CBT est devenue rentable au cours des 5 dernières années, augmentant ses bénéfices de 25.8% par an.

Accélération de la croissance: CBT a connu une croissance négative de ses bénéfices au cours de l'année écoulée, elle ne peut donc pas être comparée à sa moyenne sur 5 ans.

Bénéfices par rapport au secteur d'activité: CBT a enregistré une croissance négative de ses bénéfices ( -34% ) au cours de l'année écoulée, ce qui rend difficile la comparaison avec la moyenne du secteur Chemicals ( 0.1% ).


Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de CBT ( 19.4% ) est considéré comme faible.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/05/31 02:08
Cours de l'action en fin de journée2026/05/29 00:00
Les revenus2026/03/31
Revenus annuels2025/09/30

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Cabot Corporation est couverte par 11 analystes. 5 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Benjamin KalloBaird
Michael LeitheadBarclays
David BegleiterDeutsche Bank